Ekaterina V. Kurbatova
0000-0003-4636-3731
Publication & Citation Trends
Publications
65 total
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis OA
Cited by 0
Semantic Scholar
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Cited by 1
Semantic Scholar
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020
Cited by 0
Semantic Scholar
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.
Cited by 0
Semantic Scholar
Facilitators and barriers to adolescent participation in a TB clinical trial.
Cited by 1
Semantic Scholar
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis OA
Cited by 4
Semantic Scholar
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
Cited by 5
Semantic Scholar
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis OA
Cited by 17
Semantic Scholar
Research Topics
Tuberculosis Research and Epidemiology
(50)
Pneumocystis jirovecii pneumonia detection and treatment
(20)
Pneumonia and Respiratory Infections
(18)
Mycobacterium research and diagnosis
(16)
Infectious Diseases and Tuberculosis
(12)
Affiliations
Centers for Disease Control and Prevention
Department of Health
Emory University
The University of Texas Health Science Center at San Antonio
Lung Center of the Philippines